메뉴 건너뛰기




Volumn 31, Issue 6, 2008, Pages 557-560

High incidence of oral dysesthesias on a trial of gefitinib, paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers

Author keywords

Gefitinib; Irradiation; Oral dysesthesia; Paclitaxel

Indexed keywords

GABAPENTIN; GEFITINIB; PACLITAXEL;

EID: 58149267547     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318172d5de     Document Type: Article
Times cited : (17)

References (36)
  • 1
    • 33644516280 scopus 로고    scopus 로고
    • A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
    • Budach W, Hehr T, Budach V, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6:28.
    • (2006) BMC Cancer , vol.6 , pp. 28
    • Budach, W.1    Hehr, T.2    Budach, V.3
  • 2
    • 33748169693 scopus 로고    scopus 로고
    • Adjuvant therapy in patients with resected poor-risk head and neck cancer
    • Bernier J, Vermorken JB, Koch WM. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol. 2006;24:2629-2635.
    • (2006) J Clin Oncol , vol.24 , pp. 2629-2635
    • Bernier, J.1    Vermorken, J.B.2    Koch, W.M.3
  • 3
    • 33646684021 scopus 로고    scopus 로고
    • Radiotherapy for head and neck cancer: Latest developments and future perspectives
    • Bernier J, Bentzen SM. Radiotherapy for head and neck cancer: latest developments and future perspectives. Curr Opin Oncol. 2006;18:240-246.
    • (2006) Curr Opin Oncol , vol.18 , pp. 240-246
    • Bernier, J.1    Bentzen, S.M.2
  • 4
    • 0027183870 scopus 로고
    • Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
    • Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993;53:3579-3584.
    • (1993) Cancer Res , vol.53 , pp. 3579-3584
    • Grandis, J.R.1    Tweardy, D.J.2
  • 5
    • 30644478919 scopus 로고    scopus 로고
    • A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
    • Jermann M, Stahel RA, Salzberg M, et al. A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer Chemother Pharmacol. 2006;57:533-539.
    • (2006) Cancer Chemother Pharmacol , vol.57 , pp. 533-539
    • Jermann, M.1    Stahel, R.A.2    Salzberg, M.3
  • 7
    • 33646242760 scopus 로고    scopus 로고
    • Clinical experience with erlotinib in non-small-cell lung cancer
    • Felip E, Rosell R. Clinical experience with erlotinib in non-small-cell lung cancer. Drugs Today (Barc). 2006;42:147-156.
    • (2006) Drugs Today (Barc) , vol.42 , pp. 147-156
    • Felip, E.1    Rosell, R.2
  • 8
    • 29244448296 scopus 로고    scopus 로고
    • Radiation combined with EGFR signal inhibitors: Head and neck cancer focus
    • Harari PM, Huang S. Radiation combined with EGFR signal inhibitors: head and neck cancer focus. Semin Radiat Oncol. 2006;16:38-44.
    • (2006) Semin Radiat Oncol , vol.16 , pp. 38-44
    • Harari, P.M.1    Huang, S.2
  • 9
    • 31544433743 scopus 로고    scopus 로고
    • Epidermal growth factor receptor inhibitors in cancer treatment
    • Ciardiello F. Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol. 2005;1:221-234.
    • (2005) Future Oncol , vol.1 , pp. 221-234
    • Ciardiello, F.1
  • 10
    • 31444441698 scopus 로고    scopus 로고
    • Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology?
    • Mamot C, Rochlitz C. Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology? Swiss Med Wkly. 2006;136:4-12.
    • (2006) Swiss Med Wkly , vol.136 , pp. 4-12
    • Mamot, C.1    Rochlitz, C.2
  • 11
    • 33645017703 scopus 로고    scopus 로고
    • Optimizing chemotherapy and targeted agent combinations in NSCLC
    • Lynch T Jr, Kim E. Optimizing chemotherapy and targeted agent combinations in NSCLC. Lung Cancer. 2005;50(suppl 2):S25-S32.
    • (2005) Lung Cancer , vol.50 , Issue.SUPPL. 2
    • Lynch Jr, T.1    Kim, E.2
  • 12
    • 33645542766 scopus 로고    scopus 로고
    • Palliative chemotherapy of head and neck cancer: Present status and future development
    • Hennemann B. Palliative chemotherapy of head and neck cancer: present status and future development. Laryngorhinootologie. 2006;85:172-178.
    • (2006) Laryngorhinootologie , vol.85 , pp. 172-178
    • Hennemann, B.1
  • 13
    • 33645101097 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in non-small cell lung cancer: A basic science discovery with immediate clinical impact
    • Dowell JE. Epidermal growth factor receptor mutations in non-small cell lung cancer: a basic science discovery with immediate clinical impact. Am J Med Sci. 2006;331:139-149.
    • (2006) Am J Med Sci , vol.331 , pp. 139-149
    • Dowell, J.E.1
  • 14
    • 31544436908 scopus 로고    scopus 로고
    • Oral complications of radiotherapy
    • Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol. 2006;7:175-183.
    • (2006) Lancet Oncol , vol.7 , pp. 175-183
    • Sciubba, J.J.1    Goldenberg, D.2
  • 15
    • 0033780559 scopus 로고    scopus 로고
    • Prevention and management of mucositis in patients with cancer
    • Herrstedt J. Prevention and management of mucositis in patients with cancer. Int J Antimicrob Agents. 2000;16:161-163.
    • (2000) Int J Antimicrob Agents , vol.16 , pp. 161-163
    • Herrstedt, J.1
  • 16
    • 33645515321 scopus 로고    scopus 로고
    • Burning mouth syndrome: Clinical presentation, diagnosis and treatment
    • quiz, 82-73
    • Savage NW, Boras W, Barker K. Burning mouth syndrome: clinical presentation, diagnosis and treatment. Australas J Dermatol. 2006;47:77-81; quiz, 82-73.
    • (2006) Australas J Dermatol , vol.47 , pp. 77-81
    • Savage, N.W.1    Boras, W.2    Barker, K.3
  • 17
    • 0018102126 scopus 로고
    • Psychological aspects of glossodynia (author's transl)
    • Haneke E. Psychological aspects of glossodynia (author's transl). Dtsch Med Wochenschr. 1978;103:1302-1305.
    • (1978) Dtsch Med Wochenschr , vol.103 , pp. 1302-1305
    • Haneke, E.1
  • 18
    • 0024413012 scopus 로고
    • Glossodynia after radiation therapy and chemotherapy
    • Naylor GD, Marino GG, Shumway RC. Glossodynia after radiation therapy and chemotherapy. Ear Nose Throat J. 1989;68:751-757.
    • (1989) Ear Nose Throat J , vol.68 , pp. 751-757
    • Naylor, G.D.1    Marino, G.G.2    Shumway, R.C.3
  • 19
    • 14744271430 scopus 로고
    • Hypersensitivity reactions to oxaliplatin: Incidence and management
    • 1675; discussion, 1680
    • Gowda A, Goel R, Berdzik J, et al. Hypersensitivity reactions to oxaliplatin: incidence and management. Oncology (Williston Park). 2004;18:1671-1675; discussion, 1676, 1680, 1683-1684.
    • (1676) Oncology (Williston Park) , vol.18
    • Gowda, A.1    Goel, R.2    Berdzik, J.3
  • 20
    • 0031035115 scopus 로고    scopus 로고
    • Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur
    • Rios-Buceta L, Buezo GF, Penas PF, et al. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Acta Derm Venereol. 1997;77:80-81.
    • (1997) Acta Derm Venereol , vol.77 , pp. 80-81
    • Rios-Buceta, L.1    Buezo, G.F.2    Penas, P.F.3
  • 21
    • 33750991326 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A gynecologic oncology group study
    • Fracasso PM, Blessing JA, Molpus KL, et al. Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol. 2006;103:523-526.
    • (2006) Gynecol Oncol , vol.103 , pp. 523-526
    • Fracasso, P.M.1    Blessing, J.A.2    Molpus, K.L.3
  • 22
    • 0030742933 scopus 로고    scopus 로고
    • Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial
    • Hoffmann W, Belka C, Schmidberger H, et al. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial. Int J Radiat Oncol Biol Phys. 1997;38:691-696.
    • (1997) Int J Radiat Oncol Biol Phys , vol.38 , pp. 691-696
    • Hoffmann, W.1    Belka, C.2    Schmidberger, H.3
  • 23
    • 0031475070 scopus 로고    scopus 로고
    • A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma
    • Steinberg L, Hassan M, Olmsted L, et al. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Semin Oncol. 1997;24(suppl 19):51-56.
    • (1997) Semin Oncol , vol.24 , Issue.SUPPL. 19 , pp. 51-56
    • Steinberg, L.1    Hassan, M.2    Olmsted, L.3
  • 24
    • 10644261471 scopus 로고    scopus 로고
    • Overview of the tolerability of gefitinib (IRESSA) monotherapy: Clinical experience in non-small-cell lung cancer
    • Forsythe B, Faulkner K. Overview of the tolerability of gefitinib (IRESSA) monotherapy: clinical experience in non-small-cell lung cancer. Drug Saf. 2004;27:1081-1092.
    • (2004) Drug Saf , vol.27 , pp. 1081-1092
    • Forsythe, B.1    Faulkner, K.2
  • 25
    • 24744469035 scopus 로고    scopus 로고
    • Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): The expanded access protocol experience at the University of Pennsylvania
    • Veronese ML, Algazy K, Bearn L, et al. Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania. Cancer Invest. 2005;23:296-302.
    • (2005) Cancer Invest , vol.23 , pp. 296-302
    • Veronese, M.L.1    Algazy, K.2    Bearn, L.3
  • 26
    • 21044438337 scopus 로고    scopus 로고
    • Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: A phase I/II study conducted by the Hellenic Cooperative Oncology Group
    • Fountzilas G, Pectasides D, Kalogera-Fountzila A, et al. Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group. Breast Cancer Res Treat. 2005;92:1-9.
    • (2005) Breast Cancer Res Treat , vol.92 , pp. 1-9
    • Fountzilas, G.1    Pectasides, D.2    Kalogera-Fountzila, A.3
  • 27
    • 33644848522 scopus 로고    scopus 로고
    • Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: Phase I trial results
    • Czito BG, Willett CG, Bendell JC, et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol. 2006;24:656-662.
    • (2006) J Clin Oncol , vol.24 , pp. 656-662
    • Czito, B.G.1    Willett, C.G.2    Bendell, J.C.3
  • 28
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578,
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 29
    • 28744451855 scopus 로고    scopus 로고
    • Neuropathic pain due to malignancy: Mechanisms, clinical manifestations and therapy
    • Pjevic M, Patarica-Huber E, Radovanovic D, et al. Neuropathic pain due to malignancy: mechanisms, clinical manifestations and therapy. Med Pregl. 2004;57:33-40.
    • (2004) Med Pregl , vol.57 , pp. 33-40
    • Pjevic, M.1    Patarica-Huber, E.2    Radovanovic, D.3
  • 30
    • 0036366760 scopus 로고    scopus 로고
    • Anticonvulsants in neuropathic pain: Rationale and clinical evidence
    • Jensen T. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6:61-68.
    • (2002) Eur J Pain , vol.6 , pp. 61-68
    • Jensen, T.1
  • 31
    • 33745947782 scopus 로고    scopus 로고
    • Mechanisms of the antinociceptive action of gabapentin
    • Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100:471-486.
    • (2006) J Pharmacol Sci , vol.100 , pp. 471-486
    • Cheng, J.K.1    Chiou, L.C.2
  • 32
    • 33747171616 scopus 로고    scopus 로고
    • Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence
    • Gilron I, Flatters S. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res Manag. 2006;11:16A-29A.
    • (2006) Pain Res Manag , vol.11
    • Gilron, I.1    Flatters, S.2
  • 33
    • 58149254915 scopus 로고    scopus 로고
    • Gabapentin for the treatment of pain related to radiation-induced mucositis, in patients with head and neck cancers treated with concurrent chemoradiation using intensity modulated radiation therapy (IMRT)
    • Bar Ad V, Dutta P, Both S, et al. Gabapentin for the treatment of pain related to radiation-induced mucositis, in patients with head and neck cancers treated with concurrent chemoradiation using intensity modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2007;69:S426-S427.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69
    • Bar, A.V.1    Dutta, P.2    Both, S.3
  • 34
    • 0035855860 scopus 로고    scopus 로고
    • Molecular mechanisms of nociception
    • Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203-210.
    • (2001) Nature , vol.413 , pp. 203-210
    • Julius, D.1    Basbaum, A.I.2
  • 35
    • 0034625770 scopus 로고    scopus 로고
    • Neuronal plasticity: Increasing the gain in pain
    • Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769.
    • (2000) Science , vol.288 , pp. 1765-1769
    • Woolf, C.J.1    Salter, M.W.2
  • 36
    • 33644765967 scopus 로고    scopus 로고
    • Optical coherence tomography reveals in vivo cortical plasticity of adult mice in response to peripheral neuropathic pain
    • Ooi Y, Satomura Y, Seki J, et al. Optical coherence tomography reveals in vivo cortical plasticity of adult mice in response to peripheral neuropathic pain. Neurosci Lett. 2006;397:35-39.
    • (2006) Neurosci Lett , vol.397 , pp. 35-39
    • Ooi, Y.1    Satomura, Y.2    Seki, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.